|Articles|January 1, 2020 (Updated: November 15, 2020)
- Pharmaceutical Executive-01-01-2020
- Volume 40
- Issue 1
Pharmaceutical Executive, January 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec’s 2020 Industry Outlookabout 6 years ago
Sharing the Pricing Stage in 2020about 6 years ago
Paving Bayer’s Future Pathabout 6 years ago
Politics & Pricing to Shape Pharma Prospects in 2020about 6 years ago
Pharma’s Brexit Routeabout 6 years ago
Is the Tail Wagging the Dog in Drug Market Entry?about 6 years ago
A Happy New Year for European Pharma Policy?about 6 years ago
Deeper Dive: Gene Therapy Manufacturingabout 6 years ago
Country Report: ChinaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5